Research ExplorerPublicationsRNA interference-mediated c-MYC inhibition prevents cell gro...

RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.

Standard

RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. / von Bueren, André; André, O; Shalaby, Tarek; Oehler-Jänne, Christoph; Arnold, Lucia; Stearns, Duncan; Eberhart, Charles G; Arcaro, Alexandre; Pruschy, Martin; Grotzer, Michael A.

In: BMC CANCER, Vol. 9, 2009, p. 10.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

von Bueren, A, André, O, Shalaby, T, Oehler-Jänne, C, Arnold, L, Stearns, D, Eberhart, CG, Arcaro, A, Pruschy, M & Grotzer, MA 2009, 'RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.', BMC CANCER, vol. 9, pp. 10. <http://www.ncbi.nlm.nih.gov/pubmed/19134217?dopt=Citation>

APA

von Bueren, A., André, O., Shalaby, T., Oehler-Jänne, C., Arnold, L., Stearns, D., Eberhart, C. G., Arcaro, A., Pruschy, M., & Grotzer, M. A. (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC CANCER, 9, 10. http://www.ncbi.nlm.nih.gov/pubmed/19134217?dopt=Citation

Vancouver

von Bueren A, André O, Shalaby T, Oehler-Jänne C, Arnold L, Stearns D et al. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC CANCER. 2009;9:10.

Bibtex

@article{915aa964d63c422aa58dc657547c94aa,
title = "RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.",
abstract = "With current treatment strategies, nearly half of all medulloblastoma (MB) patients die from progressive tumors. Accordingly, the identification of novel therapeutic strategies remains a major goal. Deregulation of c-MYC is evident in numerous human cancers. In MB, over-expression of c-MYC has been shown to cause anaplasia and correlate with unfavorable prognosis.",
author = "{von Bueren}, Andr{\'e} and O Andr{\'e} and Tarek Shalaby and Christoph Oehler-J{\"a}nne and Lucia Arnold and Duncan Stearns and Eberhart, {Charles G} and Alexandre Arcaro and Martin Pruschy and Grotzer, {Michael A}",
year = "2009",
language = "Deutsch",
volume = "9",
pages = "10",
journal = "BMC CANCER",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.

AU - von Bueren, André

AU - André, O

AU - Shalaby, Tarek

AU - Oehler-Jänne, Christoph

AU - Arnold, Lucia

AU - Stearns, Duncan

AU - Eberhart, Charles G

AU - Arcaro, Alexandre

AU - Pruschy, Martin

AU - Grotzer, Michael A

PY - 2009

Y1 - 2009

N2 - With current treatment strategies, nearly half of all medulloblastoma (MB) patients die from progressive tumors. Accordingly, the identification of novel therapeutic strategies remains a major goal. Deregulation of c-MYC is evident in numerous human cancers. In MB, over-expression of c-MYC has been shown to cause anaplasia and correlate with unfavorable prognosis.

AB - With current treatment strategies, nearly half of all medulloblastoma (MB) patients die from progressive tumors. Accordingly, the identification of novel therapeutic strategies remains a major goal. Deregulation of c-MYC is evident in numerous human cancers. In MB, over-expression of c-MYC has been shown to cause anaplasia and correlate with unfavorable prognosis.

M3 - SCORING: Zeitschriftenaufsatz

VL - 9

SP - 10

JO - BMC CANCER

JF - BMC CANCER

SN - 1471-2407

ER -